Serotonin 1A receptor gene, schizophrenia and bipolar disorder: An association study and meta-analysis

Psychiatry Research

Volumn 185, Issue 1-2, 2011, Pages 20-26

  Kishi, Taro ^a   Okochi, Tomo ^a   Tsunoka, Tomoko ^a   Okumura, Takenori ^a   Kitajima, Tsuyoshi ^a   Kawashima, Kunihiro ^a   Yamanouchi, Yoshio ^a   Kinoshita, Yoko ^a   Naitoh, Hiroshi ^a   Inada, Toshiya ^b   Kunugi, Hiroshi ^c   Kato, Tadafumi ^d   Yoshikawa, Takeo ^d   Ujike, Hiroshi ^e   Ozaki, Norio ^f   Iwata, Nakao ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SEIWA HOSPITAL   (Japan)

^c NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^d RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^e OKAYAMA UNIVERSITY   (Japan)

^f NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bipolar disorder; Functional SNP; Schizophrenia; Serotonin 1A receptor gene (HTR1A); Tagging SNP

Indexed keywords

SEROTONIN 1A RECEPTOR;

ARTICLE; BIPOLAR DISORDER; CASE CONTROL STUDY; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; JAPANESE; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; BIPOLAR DISORDER; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; META-ANALYSIS AS TOPIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, SEROTONIN, 5-HT1A; SCHIZOPHRENIA;

EID: 78650202437     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2010.06.003     Document Type: Article

References (77)

1. Albert P.R., Lemonde S. 5-HT1A receptors, gene repression, and depression: guilt by association. Neuroscientist 2004, 10:575-593.
2. Albert P.R., Lembo P., Storring J.M., Charest A., Saucier C. The 5-HT1A receptor: signaling, desensitization, and gene transcription. Neuropsychopharmacology 1996, 14:19-25.
3. Allen N.C., Bagade S., McQueen M.B., Ioannidis J.P., Kavvoura F.K., Khoury M.J., Tanzi R.E., Bertram L. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nature Genetics 2008, 40:827-834.
4. Amos C.I., Martinez M., Bale S.J. Can a susceptibility locus for schizophrenia be excluded from chromosome 5q11-13?. American Journal of Human Genetics 1991, 48:1206-1209.
5. Anttila S., Huuhka K., Huuhka M., Rontu R., Hurme M., Leinonen E., Lehtimaki T. Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression. Journal of Neural Transmmission 2007, 114:1065-1068.
6. Arias B., Catalan R., Gasto C., Gutierrez B., Fananas L. Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram. Journal of Psychopharmacology (Oxford, England) 2005, 19:166-172.
7. Aznar S., Qian Z., Shah R., Rahbek B., Knudsen G.M. The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain. Brain Research 2003, 959:58-67.
8. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38:1083-1152.
9. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (Oxford, England) 2005, 21:263-265.
10. Burnet P.W., Eastwood S.L., Harrison P.J. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology 1996, 15:442-455.
11. Consortium W.T.C.C. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 2007, 447:661-678.
12. DerSimonian R., Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986, 7:177-188.
13. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genetic Epidemiology 2003, 25:115-121.
14. Geyer M.A., Vollenweider F.X. Serotonin research: contributions to understanding psychoses. Trends in Pharmacological Sciences 2008, 29:445-453.
15. Green E.K., Grozeva, D., Jones I., Kirov G., Caesar S., Gordon-Smith K., Fraser C., Forty L., Russell E., Hamshere M.L., Moskvina V., Nikolov I., Farmer A., McGuffin P., Holmans P.A., Owen M.J., O'Donovan M.C., Craddock N. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Molecular Psychiatry 2010, 15(10):1016-1022.
16. Hallmayer J., Maier W., Ackenheil M., Ertl M.A., Schmidt S., Minges J., Lichtermann D., Wildenauer D. Evidence against linkage of schizophrenia to chromosome 5q11-q13 markers in systematically ascertained families. Biological Psychiatry 1992, 31:83-94.
17. Hashimoto T., Nishino N., Nakai H., Tanaka C. Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia. Life Sciences 1991, 48:355-363.
18. Hashimoto T., Kitamura N., Kajimoto Y., Shirai Y., Shirakawa O., Mita T., Nishino N., Tanaka C. Differential changes in serotonin 5-HT1A and 5-HT2 receptor binding in patients with chronic schizophrenia. Psychopharmacology 1993, 112:S35-S39.
19. Hashimoto R., Numakawa T., Ohnishi T., Kumamaru E., Yagasaki Y., Ishimoto T., Mori T., Nemoto K., Adachi N., Izumi A., Chiba S., Noguchi H., Suzuki T., Iwata N., Ozaki N., Taguchi T., Kamiya A., Kosuga A., Tatsumi M., Kamijima K., Weinberger D.R., Sawa A., Kunugi H. Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Human Molecular Genetics 2006, 15:3024-3033.
20. Hattori E., Toyota T., Ishitsuka Y., Iwayama Y., Yamada K., Ujike H., Morita Y., Kodama M., Nakata K., Minabe Y., Nakamura K., Iwata Y., Takei N., Mori N., Naitoh H., Yamanouchi Y., Iwata N., Ozaki N., Kato T., Nishikawa T., Kashiwa A., Suzuki M., Shioe K., Shinohara M., Hirano M., Nanko S., Akahane A., Ueno M., Kaneko N., Watanabe Y., Someya T., Hashimoto K., Iyo M., Itokawa M., Arai M., Nankai M., Inada T., Yoshida S., Kunugi H., Nakamura M., Iijima Y., Okazaki Y., Higuchi T., Yoshikawa T. Preliminary genome-wide association study of bipolar disorder in the Japanese population. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2009, 150B(8):1110-1117.
21. Hennah W., Varilo T., Kestila M., Paunio T., Arajarvi R., Haukka J., Parker A., Martin R., Levitzky S., Partonen T., Meyer J., Lonnqvist J., Peltonen L., Ekelund J. Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Human Molecular Genetics 2003, 12:3151-3159.
22. Hennah W., Tuulio-Henriksson A., Paunio T., Ekelund J., Varilo T., Partonen T., Cannon T.D., Lonnqvist J., Peltonen L. A haplotype within the DISC1 gene is associated with visual memory functions in families with a high density of schizophrenia. Molecular Psychiatry 2005, 10:1097-1103.
23. Hong C.J., Chen T.J., Yu Y.W., Tsai S.J. Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder. The Pharmacogenomics Journal 2006, 6:27-33.
24. Huang Y.Y., Battistuzzi C., Oquendo M.A., Harkavy-Friedman J., Greenhill L., Zalsman G., Brodsky B., Arango V., Brent D.A., Mann J.J. Human 5-HT1A receptor C(-1019)G polymorphism and psychopathology. The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2004, 7:441-451.
25. Ikeda M., Aleksic B., Kirov G., Kinoshita Y., Yamanouchi Y., Kitajima T., Kawashima K., Okochi T., Kishi T., Zaharieva I., Owen M.J., O'Donovan M.C., Ozaki N., Iwata N. Copy Number Variation in Schizophrenia in the Japanese Population. Biological Psychiatry 2010, 67(3):283-286. (Epub 2009 Oct 31).
26. Ivleva E.I., Morris D.W., Moates A.F., Suppes T., Thaker G.K., Tamminga C.A. Genetics and intermediate phenotypes of the schizophrenia-bipolar disorder boundary. Neuroscience and Biobehavioral Reviews 2010, 34(6):897-921.
27. Kalsi G., Mankoo B., Curtis D., Sherrington R., Melmer G., Brynjolfsson J., Sigmundsson T., Read T., Murphy P., Petursson H., Gurling H. New DNA markers with increased informativeness show diminished support for a chromosome 5q11-13 schizophrenia susceptibility locus and exclude linkage in two new cohorts of British and Icelandic families. Annals of Human Genetics 1999, 63:235-247.
28. Kawanishi Y., Harada S., Tachikawa H., Okubo T., Shiraishi H. Novel mutations in the promoter and coding region of the human 5-HT1A receptor gene and association analysis in schizophrenia. American Journal of Medical Genetics 1998, 81:434-439.
29. Kawashima K., Ikeda M., Kishi T., Kitajima T., Yamanouchi Y., Kinoshita Y., Okochi T., Aleksic B., Tomita M., Okada T., Kunugi H., Inada T., Ozaki N., Iwata N. BDNF is not associated with schizophrenia: Data from a Japanese population study and meta-analysis. Schizophrenia Research 2009, 112(1-3):72-79.
30. Kishi T., Ikeda M., Kitajima T., Suzuki T., Yamanouchi Y., Kinoshita Y., Kawashima K., Ozaki N., Iwata N. No association between prostate apoptosis response 4 gene (PAWR) in schizophrenia and mood disorders in a Japanese population. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2008, 147B:531-534.
31. Kishi T., Kitajima T., Ikeda M., Yamanouchi Y., Kinoshita Y., Kawashima K., Okochi T., Ozaki N., Iwata N. Association analysis of nuclear receptor Rev-erb alpha gene (NR1D1) with mood disorders in the Japanese population. Neuroscience Research 2008, 62:211-215.
32. Kishi T., Kitajima T., Ikeda M., Yamanouchi Y., Kinoshita Y., Kawashima K., Okochi T., Okumura T., Tsunoka T., Ozaki N., Iwata N. CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patients. Neuromolecular Medicine 2009, 11:53-57.
33. Kishi T., Tsunoka T., Ikeda M., Kawashima K., Okochi T., Kitajima T., Kinoshita Y., Okumura T., Yamanouchi Y., Inada T., Ozaki N., Iwata N. Serotonin 1A receptor gene and major depressive disorder: an association study and meta-analysis. Journal of Human Genetics 2009, 54(11):629-633.
34. Kishi T., Tsunoka T., Ikeda M., Kitajima T., Kawashima K., Okochi T., Okumura T., Yamanouchi Y., Kinoshita Y., Ujike H., Inada T., Yamada M., Uchimura N., Sora I., Iyo M., Ozaki N., Iwata N. Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients. Neuropharmacology 2009, 58(2):452-456.
35. Kong A., Steinthorsdottir V., Masson G., Thorleifsson G., Sulem P., Besenbacher S., Jonasdottir A., Sigurdsson A., Kristinsson K.T., Jonasdottir A., Frigge M.L., Gylfason A., Olason P.I., Gudjonsson S.A., Sverrisson S., Stacey S.N., Sigurgeirsson B., Benediktsdottir K.R., Sigurdsson H., Jonsson T., Benediktsson R., Olafsson J.H., Johannsson O.T., Hreidarsson A.B., Sigurdsson G., Ferguson-Smith A.C., Gudbjartsson D.F., Thorsteinsdottir U., Stefansson K. Parental origin of sequence variants associated with complex diseases. Nature 2009, 462:868-874.
36. Kraus M.R., Al-Taie O., Schafer A., Pfersdorff M., Lesch K.P., Scheurlen M. Serotonin-1A receptor gene HTR1A variation predicts interferon-induced depression in chronic hepatitis C. Gastroenterology 2007, 132:1279-1286.
37. Le Francois B., Czesak M., Steubl D., Albert P.R. Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology 2008, 55:977-985.
38. Lemonde S., Turecki G., Bakish D., Du L., Hrdina P.D., Bown C.D., Sequeira A., Kushwaha N., Morris S.J., Basak A., Ou X.M., Albert P.R. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. Journal of Neuroscience 2003, 23:8788-8799.
39. Lemonde S., Du L., Bakish D., Hrdina P., Albert P.R. Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response. The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2004, 7:501-506.
40. Macciardi F., Kennedy J.L., Ruocco L., Giuffra L., Carrera P., Marino C., Rinaldi V., Smeraldi E., Ferrari M. A genetic linkage study of schizophrenia to chromosome 5 markers in a northern Italian population. Biological Psychiatry 1992, 31:720-728.
41. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., McCarthy M.I., Ramos E.M., Cardon L.R., Chakravarti A., Cho J.H., Guttmacher A.E., Kong A., Kruglyak L., Mardis E., Rotimi C.N., Slatkin M., Valle D., Whittemore A.S., Boehnke M., Clark A.G., Eichler E.E., Gibson G., Haines J.L., Mackay T.F., McCarroll S.A., Visscher P.M. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
42. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959, 22:719-748.
43. Mason S.L., Reynolds G.P. Clozapine has sub-micromolar affinity for 5-HT1A receptors in human brain tissue. European Journal of Pharmacology 1992, 221:397-398.
44. McGuffin P., Sargeant M., Hetti G., Tidmarsh S., Whatley S., Marchbanks R.M. Exclusion of a schizophrenia susceptibility gene from the chromosome 5q11-q13 region: new data and a reanalysis of previous reports. American Journal of Human Genetics 1990, 47:524-535.
45. Meltzer H.Y., Sumiyoshi T. Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia?. Behavioural Brain Research 2008, 195:98-102.
46. Meltzer H.Y., Li Z., Kaneda Y., Ichikawa J. Serotonin receptors: their key role in drugs to treat schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2003, 27:1159-1172.
47. Moskvina V., Craddock N., Holmans P., Nikolov I., Pahwa J.S., Green E., Owen M.J., O'Donovan M.C. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Molecular Psychiatry 2009, 14:252-260.
48. Mossner R., Schuhmacher A., Kuhn K.U., Cvetanovska G., Rujescu D., Zill P., Quednow B.B., Rietschel M., Wolwer W., Gaebel W., Wagner M., Maier W. Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia. Pharmacogenetics and Genomics 2009, 19:91-94.
49. Neale B.M., Sham P.C. The future of association studies: gene-based analysis and replication. American Journal of Human Genetics 2004, 75:353-362.
50. Neff C.D., Abkevich V., Packer J.C., Chen Y., Potter J., Riley R., Davenport C., Degrado Warren J., Jammulapati S., Bhathena A., Choi W.S., Kroeger P.E., Metzger R.E., Gutin A., Skolnick M.H., Shattuck D., Katz D.A. Evidence for HTR1A and LHPP as interacting genetic risk factors in major depression. Molecular Psychiatry 2009, 14(6):621-630.
51. Ng M.Y., Levinson D.F., Faraone S.V., Suarez B.K., DeLisi L.E., Arinami T., Riley B., Paunio T., Pulver A.E., Irmansyah, Holmans P.A., Escamilla M., Wildenauer D.B., Williams N.M., Laurent C., Mowry B.J., Brzustowicz L.M., Maziade M., Sklar P., Garver D.L., Abecasis G.R., Lerer B., Fallin M.D., Gurling H.M., Gejman P.V., Lindholm E., Moises H.W., Byerley W., Wijsman E.M., Forabosco P., Tsuang M.T., Hwu H.G., Okazaki Y., Kendler K.S., Wormley B., Fanous A., Walsh D., O'Neill F.A., Peltonen L., Nestadt G., Lasseter V.K., Liang K.Y., Papadimitriou G.M., Dikeos D.G., Schwab S.G., Owen M.J., O'Donovan M.C., Norton N., Hare E., Raventos H., Nicolini H., Albus M., Maier W., Nimgaonkar V.L., Terenius L., Mallet J., Jay M., Godard S., Nertney D., Alexander M., Crowe R.R., Silverman J.M., Bassett A.S., Roy M.A., Merette C., Pato C.N., Pato M.T., Roos J.L., Kohn Y., Amann-Zalcenstein D., Kalsi G., McQuillin A., Curtis D., Brynjolfson J., Sigmundsson T., Petursson H., Sanders A.R., Duan J., Jazin E., Myles-Worsley M., Karayiorgou M., Lewis C.M. Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Molecular Psychiatry 2009, 14:774-785.
52. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., Nikolov I., Hamshere M., Carroll L., Georgieva L., Dwyer S., Holmans P., Marchini J.L., Spencer C.C., Howie B., Leung H.T., Hartmann A.M., Moller H.J., Morris D.W., Shi Y., Feng G., Hoffmann P., Propping P., Vasilescu C., Maier W., Rietschel M., Zammit S., Schumacher J., Quinn E.M., Schulze T.G., Williams N.M., Giegling I., Iwata N., Ikeda M., Darvasi A., Shifman S., He L., Duan J., Sanders A.R., Levinson D.F., Gejman P.V., Cichon S., Nothen M.M., Gill M., Corvin A., Rujescu D., Kirov G., Owen M.J., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Cloninger C.R. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nature Genetics 2008, 40:1053-1055.
53. O'Donovan M.C., Craddock N.J., Owen M.J. Genetics of psychosis; insights from views across the genome. Human Genetics 2009, 126:3-12.
54. Okochi T., Ikeda M., Kishi T., Kawashima K., Kinoshita Y., Kitajima T., Yamanouchi Y., Tomita M., Inada T., Ozaki N., Iwata N. Meta-analysis of association between genetic variants in COMT and schizophrenia: an update. Schizophrenia Research 2009, 110:140-148.
55. Palo O.M., Antila M., Silander K., Hennah W., Kilpinen H., Soronen P., Tuulio-Henriksson A., Kieseppa T., Partonen T., Lonnqvist J., Peltonen L., Paunio T. Association of distinct allelic haplotypes of DISC1 with psychotic and bipolar spectrum disorders and with underlying cognitive impairments. Human Molecular Genetics 2007, 16:2517-2528.
56. Parsey R.V., Olvet D.M., Oquendo M.A., Huang Y.Y., Ogden R.T., Mann J.J. Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology 2006, 31:1745-1749.
57. Purcell S., Cherny S.S., Sham P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics (Oxford, England) 2003, 19:149-150.
58. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
59. Reynolds G.P., Arranz B., Templeman L.A., Fertuzinhos S., San L. Effect of 5-HT1A receptor gene polymorphism on negative and depressive symptom response to antipsychotic treatment of drug-naive psychotic patients. The American Journal of Psychiatry 2006, 163:1826-1829.
60. Schosser A., Gaysina D., Cohen-Woods S., Chow P.C., Martucci L., Craddock N., Farmer A., Korszun A., Gunasinghe C., Gray J., Jones L., Tozzi F., Perry J., Muglia P., Owen M.J., Craig I.W., McGuffin P. Association of DISC1 and TSNAX genes and affective disorders in the depression case-control (DeCC) and bipolar affective case-control (BACCS) studies. Molecular Psychiatry 2010, 15(8):844-849.
61. Serretti A., Artioli P., Lorenzi C., Pirovano A., Tubazio V., Zanardi R. The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings. The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2004, 7:453-460.
62. Shi J., Badner J.A., Gershon E.S., Liu C. Allelic association of G72/G30 with schizophrenia and bipolar disorder: a comprehensive meta-analysis. Schizophrenia Research 2008, 98:89-97.
63. Shi J., Levinson D.F., Duan J., Sanders A.R., Zheng Y., Pe'er I., Dudbridge F., Holmans P.A., Whittemore A.S., Mowry B.J., Olincy A., Amin F., Cloninger C.R., Silverman J.M., Buccola N.G., Byerley W.F., Black D.W., Crowe R.R., Oksenberg J.R., Mirel D.B., Kendler K.S., Freedman R., Gejman P.V. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009, 460:753-757.
64. Simpson M.D., Lubman D.I., Slater P., Deakin J.F. Autoradiography with [3H]8-OH-DPAT reveals increases in 5-HT(1A) receptors in ventral prefrontal cortex in schizophrenia. Biological Psychiatry 1996, 39:919-928.
65. Strobel A., Gutknecht L., Rothe C., Reif A., Mossner R., Zeng Y., Brocke B., Lesch K.P. Allelic variation in 5-HT1A receptor expression is associated with anxiety- and depression-related personality traits. Journalof NeuralTransmission 2003, 110:1445-1453.
66. Sullivan G.M., Ogden R.T., Oquendo M.A., Kumar J.S., Simpson N., Huang Y.Y., Mann J.J., Parsey R.V. Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression. Biological Psychiatry 2009, 66:223-230.
67. Sumiyoshi T., Stockmeier C.A., Overholser J.C., Dilley G.E., Meltzer H.Y. Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia. Brain Research 1996, 708:209-214.
68. Sumiyoshi T., Matsui M., Nohara S., Yamashita I., Kurachi M., Sumiyoshi C., Jayathilake K., Meltzer H.Y. Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment. The American Journal of Psychiatry 2001, 158:1722-1725.
69. Sumiyoshi T., Matsui M., Yamashita I., Nohara S., Kurachi M., Uehara T., Sumiyoshi S., Sumiyoshi C., Meltzer H.Y. The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia. Biological Psychiatry 2001, 49:861-868.
70. Sumiyoshi T., Park S., Jayathilake K., Roy A., Ertugrul A., Meltzer H.Y. Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study. Schizophrenia Research 2007, 95:158-168.
71. Sumiyoshi T., Bubenikova-Valesova V., Horacek J., Bert B. Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics. Advances in Therapy 2008, 25:1037-1056.
72. Thomson P.A., Wray N.R., Millar J.K., Evans K.L., Hellard S.L., Condie A., Muir W.J., Blackwood D.H., Porteous D.J. Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Molecular Psychiatry 2005, 10(657-668):616.
73. Varnas K., Halldin C., Hall H. Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Human Brain Mapping 2004, 22:246-260.
74. Wang L., Fang C., Zhang A., Du J., Yu L., Ma J., Feng G., Xing Q., He L. The --1019 C/G polymorphism of the 5-HT(1)A receptor gene is associated with negative symptom response to risperidone treatment in schizophrenia patients. Journal of psychopharmacology (Oxford, England) 2008, 22:904-909.
75. Yamaguchi-Kabata Y., Nakazono K., Takahashi A., Saito S., Hosono N., Kubo M., Nakamura Y., Kamatani N. Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. American Journal of Human Genetics 2008, 83:445-456.
76. Yu Y.W., Tsai S.J., Liou Y.J., Hong C.J., Chen T.J. Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders. European Neuropsychopharmacology 2006, 16:498-503.
77. Zhang X., Tochigi M., Ohashi J., Maeda K., Kato T., Okazaki Y., Kato N., Tokunaga K., Sawa A., Sasaki T. Association study of the DISC1/TRAX locus with schizophrenia in a Japanese population. Schizophrenia Research 2005, 79:175-180.